| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 03/18/2004 | CA2493974A1 Pharmaceutical dosage form comprising a sulfite compound |
| 03/17/2004 | EP1398025A1 Fine inorganic particles having drug included therein, method for preparation thereof and pharmaceutical preparation comprising fine inorganic particles having drug included therein |
| 03/17/2004 | EP1398024A2 Uses for thyroid hormone compounds |
| 03/17/2004 | EP1397369A1 New use or cyclolignans and new cyclolignans |
| 03/17/2004 | EP1397368A1 New use of specific cyclolignans |
| 03/17/2004 | EP1397365A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators |
| 03/17/2004 | EP1397155A1 Sustained release formulation |
| 03/17/2004 | EP1397150A2 Somatostatin agonists |
| 03/17/2004 | EP1397142A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 03/17/2004 | EP0825885B1 Pulmonary delivery of aerosolized medicaments |
| 03/17/2004 | CN1483034A Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 03/17/2004 | CN1483021A Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 03/17/2004 | CN1481865A Complex plant estrogen formulation which can delay female senility and method preparing same |
| 03/17/2004 | CN1481723A Dietary supplements for regulating male hormone |
| 03/16/2004 | US6706762 Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases |
| 03/16/2004 | US6706727 ethyl-4-chloro- or 4-hydroxy- Ascomycin derivatives; pimecrolimus homologues; cultivating Streptomyces hygroscopius to produce the 4-hydroxy derivative; replacement of the hydroxy with chloro under epimerization; antiinflammatory; immunosupression |
| 03/16/2004 | US6706725 Vitamin D analogues |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/16/2004 | US6706711 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 03/16/2004 | US6706710 Form of (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 03/16/2004 | US6706700 Novel steroids containing a 14 beta ,15 beta - cyclopropane ring and a 17 alpha hydroxymethyl group; male contraceptives |
| 03/16/2004 | US6706682 Increasing or maintaining the blood supply in the penis |
| 03/16/2004 | CA2079143C Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/11/2004 | WO2004019958A1 Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof |
| 03/11/2004 | WO2004019949A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | WO2004019902A1 Adhesive gel composition for iontophoresis preparation and process for producing the same |
| 03/11/2004 | WO2003066585A3 Polymer-based compositions for sustained release |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | US20040049072 RXR modulators with improved pharmacologic profile |
| 03/11/2004 | US20040049032 Inhibitors of protein kinases, especially Aurora kinase; anticancer agents |
| 03/11/2004 | US20040049017 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 03/11/2004 | US20040048919 Related to premenstrual syndrome, premenstrual dysphoric disorder, perimenopause, menopause, or side effects of hormonal contraceptives; combination of polyunsaturated fatty acid and tocopherol derivative, most of which is not alpha |
| 03/11/2004 | US20040048912 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/11/2004 | US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc. |
| 03/11/2004 | US20040048881 Quinazoline derivatives with anti-tumour activity |
| 03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 03/11/2004 | US20040048841 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
| 03/11/2004 | US20040048830 Administering a cyclic oligosaccharide such as 6-per-deoxy-6-per-(2,3- dihydroxypropylthio)- gamma -cyclodextrin; treating depression and other psychological disorders such as Cushing's syndrome, schizophrenia and severe anxiety |
| 03/11/2004 | US20040048812 Health supplement |
| 03/11/2004 | US20040048800 Use of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 03/11/2004 | US20040048372 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | CA2496920A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396492A1 Prodrug of an ice inhibitor |
| 03/10/2004 | EP1396271A1 Use of germination-activated ganoderma lucidium spores as anti-aging agent and against menopause symptoms |
| 03/10/2004 | EP1396255A1 Method for suppressing reduction of elasticity of skin |
| 03/10/2004 | EP1395604A1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 03/10/2004 | EP1395581A2 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |
| 03/10/2004 | EP1395563A1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 03/10/2004 | EP1395538A1 Vitamin d analogues |
| 03/10/2004 | EP1395305A1 Using supercritical fluids to infuse therapeutic on a medical device |
| 03/10/2004 | EP1395286A2 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| 03/10/2004 | EP1237855B1 Crystalline form of (s)-2 ethoxy-3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid |
| 03/10/2004 | EP1163244B1 Thienopyrimidine compounds, their production and use |
| 03/10/2004 | EP1112275B9 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 03/10/2004 | CN1481388A 14(15)-unsturated 15-and/or 16-substituted androgens with mixed androgen-progestational profile |
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/10/2004 | CN1480454A Antagon of endostadin receptor pyrazole carboxylic acids |
| 03/10/2004 | CN1141295C Indoline derivatives as progesterohe antagonists |
| 03/10/2004 | CN1141145C Application of medicine for treating thyroidism accompanied by infiltrative exorbitism |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/09/2004 | US6703381 Administering amphiphilic enkephalin-oligomer conjugate |
| 03/09/2004 | CA2086343C Sustained release thyroactive composition |
| 03/04/2004 | WO2004018670A1 Inhibitor of physiological activity of annexin 5 |
| 03/04/2004 | WO2004018491A1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds |
| 03/04/2004 | WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators |
| 03/04/2004 | WO2004018421A1 Idol derivatives as new thyroid receptor agonist ligands and methods |
| 03/04/2004 | WO2004018420A1 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists |
| 03/04/2004 | WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 03/04/2004 | WO2004017983A1 Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof |
| 03/04/2004 | WO2004017948A2 Use of lck inhibitor for treatment of immunologic diseases |
| 03/04/2004 | WO2004001020A3 Methods and means to promote gut absorption |
| 03/04/2004 | WO2003079993A3 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION |
| 03/04/2004 | WO2003051365A3 Use of compounds of the benzamide family as immunosuppressant |
| 03/04/2004 | WO2003050067A3 Vitamin d analogues |
| 03/04/2004 | WO2003037928A3 Analogs of human growth hormone-releasing hormone, their preparation and use |
| 03/04/2004 | WO2003000846A3 A novel g protein-coupled receptor, gave 3 |
| 03/04/2004 | WO2002015938A8 Testosterone ester formulation for human use |
| 03/04/2004 | US20040044241 Novel succinate salt of O-desmethyl-venlafaxine |
| 03/04/2004 | US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040043993 Premenstrual tension; anticancer agents; osteoporosis; hormone replacement therapy |
| 03/04/2004 | US20040043976 16Alpha-methyl or ethyl substituted estrogens |
| 03/04/2004 | US20040043971 Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
| 03/03/2004 | EP1393077A2 Method for identifying ligands for g protein coupled receptors |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392733A2 Mammalian tumor susceptibility gene products and their uses |
| 03/03/2004 | EP1392699A1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 03/03/2004 | EP1392689A1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists |
| 03/03/2004 | EP1392389A2 Microprojection array having a beneficial agent containing coating |
| 03/03/2004 | EP1392366A1 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 03/03/2004 | EP1392337A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 03/03/2004 | EP1392320A1 17-METHYLENE-ANDROSTAN-3a-OL ANALOGS AS CRH INHIBITORS |
| 03/03/2004 | EP1392307A1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 03/03/2004 | EP1392276A1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
| 03/03/2004 | EP1392275A1 Use of protein and essential amino acids to treat amenorrhea and related disorders |